Current Medical Science

Current Medical Science

当前医学

  • 4区 中科院分区
  • Q3 JCR分区

期刊简介

《Current Medical Science》是由Huazhong University of Science and Technology出版社于1981年创办的英文国际期刊(ISSN: 2096-5230,E-ISSN: 2523-899X),该期刊长期致力于医学:研究与实验领域的创新研究,主要研究方向为Biochemistry, Genetics and Molecular Biology-Genetics。作为SCI、SCIE收录期刊(JCR分区 Q3,中科院 4区),本刊采用OA未开放获取模式(OA占比0.0135...%),以发表医学:研究与实验领域等方向的原创性研究为核心(研究类文章占比81.95%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在133篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Current Medical Science该刊近年未被列入国际预警名单,年发文量约133篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 133 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
4区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
4区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 126 / 191

34.3

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 129 / 191

32.72

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 122 / 189

35.7

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 110 / 189

42.06

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:3.3 SJR:0.541 SNIP:0.484
学科类别 分区 排名 百分位
大类:Medicine 小类:General Medicine Q2 171 / 669

74%

大类:Medicine 小类:Genetics Q3 228 / 357

36%

大类:Medicine 小类:Biochemistry Q3 302 / 448

32%

期刊发文

  • Strategies for Evading Cellular Immunity Against Recombinant AAV Vectors in Gene Therap

    Author: Wang, Zi-yang; Wu, Xiao-fei; Fu, Di-yi; Li, Xiu-qi; Liu, Dan; Liu, Shu-peng; Zhao, Qian; Wang, Hong-yun

    Journal: CURRENT MEDICAL SCIENCE. 2026; Vol. 46, Issue 2, pp. 347-366. DOI: 10.1007/s11596-026-00178-9

  • LATS1/2 Inhibitor Attenuates Osteoclast Differentiation via Hippo-YAP/TAZ Signaling Pathway and Alleviates Osteoporosis in Ovariectomized Rat

    Author: Chen, Si-hui; Jiang, Yi; Xie, Guo-qing; Fang, Zhi-hao; Zhang, Bu-yi; Jiang, Chun-yu; Zhu, Jin-yu

    Journal: CURRENT MEDICAL SCIENCE. 2026; Vol. 46, Issue 2, pp. 506-517. DOI: 10.1007/s11596-026-00182-z

  • Subsequent Pregnancy Outcomes After Conservative Treatment of Postpartum Hemorrhage Following Cesarean Deliver

    Author: Qu, Xiao-xian; Zhou, Wen-ting; Landon, Mark; Rood, Kara; Liu, Xiao-hua

    Journal: CURRENT MEDICAL SCIENCE. 2026; Vol. 46, Issue 2, pp. 417-423. DOI: 10.1007/s11596-026-00164-1

  • Chromosome Karyotyping in Hematological Malignancies: Current Status and Future Direction

    Author: Xu, Cheng-yang; Zheng, Bo; Chen, Jia-le; Zhou, Jie-yi; Hu, Guan-qian; Yi, Ke; Du, Wei-tong; He, Jie; Li, Rong

    Journal: CURRENT MEDICAL SCIENCE. 2026; Vol. 46, Issue 2, pp. 307-317. DOI: 10.1007/s11596-026-00188-7

  • Targeting the Gut-Liver Mitochondria Axis in MASLD: Mechanisms and Therapeutic Perspective

    Author: Wang, Yu-hang; He, Xue-song; Lin, Li; Ning, Lu-lu; Zhao, Ya; Zhang, Meng-xiao; Chen, Le; Chen, Min

    Journal: CURRENT MEDICAL SCIENCE. 2026; Vol. 46, Issue 2, pp. 283-296. DOI: 10.1007/s11596-026-00190-z

  • Associations of Lipid and Adiposity Indices with Vascular Aging Stages in a Multicenter Chinese Populatio

    Author: Shang, Sha-sha; Ruan, Lei; Huang, Yi; Liu, Yu; Zhang, Yu-cong; Sun, Jing-yao; Kong, Chan; Zheng, Kai; Zhang, Cun-tai

    Journal: CURRENT MEDICAL SCIENCE. 2026; Vol. 46, Issue 2, pp. 399-416. DOI: 10.1007/s11596-026-00177-w

  • Perforator Propeller Flap for Donor-Site Closure of the Lower Trapezius Musculocutaneous Flap: A Case Series and Systematic Review of Buddy Flap Technique

    Author: Yuan, Yu-tong; Jin, Sheng-yang; Wang, Dan-ying; Zhu, Shan; Zang, Meng-qing; Li, Shan-shan; Chen, Zi-xiang; Liu, Yuan-bo

    Journal: CURRENT MEDICAL SCIENCE. 2026; Vol. 46, Issue 2, pp. 549-562. DOI: 10.1007/s11596-026-00189-6

  • Cadonilimab Plus Lenvatinib Combined with Stereotactic Body Radiotherapy for Conversion Therapy in Unresectable or Potentially Resectable Hepatocellular Carcinoma: A Study Protoco

    Author: Fu, Jia-jia; Zhang, Jin-feng; Liu, Dong-en; Lin, Zhen-yu; Liu, Hong-li; Hu, Jian-li; Zhang, Tao; Tang, Jing; Xue, Jun

    Journal: CURRENT MEDICAL SCIENCE. 2026; Vol. 46, Issue 2, pp. 563-572. DOI: 10.1007/s11596-026-00180-1